Subcutaneous NTG for US Radial Artery Cannulation (NTG-US-art)

A

AlRefaey Kandeel

Status

Completed

Conditions

Morbid Obesity

Treatments

Drug: Subcutaneous saline
Drug: Subcutaneous nitroglycrin

Study type

Interventional

Funder types

Other

Identifiers

NCT03006640
Refa-NTG-art

Details and patient eligibility

About

Clinicians are increasingly dealing with morbid obese patients. In morbid obese patients, difficult sampling and problems encountered with noninvasive blood pressure monitoring makes arterial cannulation an essential skill in many situations like surgeries or trans-radial procedures for coronary or carotid interventions. Radial artery has been preferred over other sites for arterial cannulation due to low incidence of bleeding, better hemostats, more comfort, and immediate ambulation. sm In this study, subcutaneous nitroglycerin will be used to facilitate radial artery cannulation aiming to decrease insertion time, increase success rate and decrease related complications

Enrollment

60 patients

Sex

All

Ages

20 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

morbid obese indicated for radial artery cannuulation

Exclusion criteria

+ve allen test peripheral arterial disease refusal

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups, including a placebo group

Control group
Placebo Comparator group
Treatment:
Drug: Subcutaneous saline
NTG group
Active Comparator group
Treatment:
Drug: Subcutaneous nitroglycrin

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems